NAXE and neoplasm: To further determine the combined inhibitory effect of AIBP and APOA-I on tumor growth, we subcutaneously injected only HCT116-AIBP cells into the flanks of nude mice, and the APOA-I recombinant protein was then administered intravenously once every 3 days for 4 cycles.